Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells

Head and Neck

Volumn 29, Issue 4, 2007, Pages 335-340

  Nam, Woong ^a   Tak, Jungae ^b   Ryu, Ju Kyoung ^a   Jung, Mankil ^b   Yook, Jong In ^a   Kim, Hyung Jun ^a   Cha, In Ho ^a  

^a Yonsei University College of Dentistry   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Antitumor activity; Apoptosis; Artemisinin; Deoxoartemisinin

Indexed keywords

12 (2' ETHYLTHIO) DEOXOARTEMISININ; 12 (2' HYDROXYETHYL) DEOXOARTEMISININ; ARTEMISININ; ARTEMISININ DERIVATIVE; CISPLATIN; DIHYDROARTEMISININ; DIHYDROARTEMISININ 12 BENZOIC ACID; FLUOROURACIL; PACLITAXEL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; HUMAN; HUMAN CELL; MOUTH CANCER; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; ARTEMISIA; ARTEMISININS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; DNA FRAGMENTATION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MOUTH NEOPLASMS; SESQUITERPENES; TUMOR CELLS, CULTURED;

EID: 34247255872     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20524     Document Type: Article

References (23)

1. Peterson LJ, Indresano AT, Marciani RD, Roser SM. Principles of oral and maxillofacial surgery. Philadelphia: JB Lippincott; 1992.
2. Zhang DY, Wu J, Ye F, et al. Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis. Cancer Res 2003;63:4037-4043.
3. Jayaprakasam B, Seeram NP, Nair MG. Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana. Cancer Lett 2003;189:11-16.
4. Lee E, Surh Y-J. Induction of apoptosis in HL-60 cells by pungent vanilloids, [6]-gingerol and [6]-paradol. Cancer Lett 1998;134:163-168.
5. Klayman DL. Qinghaosu (artemisinin): an antimalarial drug from China. Science 1985;228:1049-1055.
6. Hien TT, White NJ. Qinghaosu. Lancet 1993;341:603-608.
7. Woerdenbag HJ, Moskal TA, Pras N, et al. Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells. J Nat Prod 1993;56:849-856.
8. Efferth T, Olbrich A, Bauer R. mRNA expression profiles for the response of human tumor cell lines to the anti-malarial drugs artesunate, arteether, and artemether. Biochem Pharmacol 2002;64:617-623.
9. Jung M, Lee S, Ham J, Lee K, Kim H, Kim SK. Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer. J Med Chem 2003;46:987-994.
10. Efferth T. Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy. Drug Resist Updat 2005;8:85-97.
11. Yamachika E, Habte T, Oda D. Artemisinin: an alternative treatment for oral squamous cell carcinoma. Anticancer Res 2004;24:2153-2160.
12. Datta R, Kojima H, Yoshida K, Kufe D. Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis. J Biol Chem 1997;272:20317-20320.
13. Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997;89:175-184.
14. D'Amours D, Germain M, Orth K, Dixit VM, Poirier GG. Proteolysis of poly (ADP-ribose) polymerase by caspase 3: kinetics of cleavage of mono (ADP-ribosyl)ated and DNA-bound substrates. Radiat Res 1998;150:3-10.
15. Mao L, Hong WK, Papadimitrakopoulou VA. Focus on head and neck cancer. Cancer Cell 2004;5:311-316.
16. Grau JJ, Domingo J, Blanch JL, et al. Multidisciplinary approach in advanced cancer of the oral cavity: outcome with neoadjuvant chemotherapy according to intention-to-treat local therapy. A phase II study. Oncology 2002;63:338-345.
17. Close LG, Larson DL, Shah JP. Essentials of head and neck oncology. New York: Thieme; 1998.
18. Wall ME, Wani MC. Camptothecin and Taxol: discovery to clinic. Med Res Rev 1998;18:299-314.
19. Meshnick SR. Artemisinin: mechanisms of action, resistance and toxicity. Int J Parasitol 2002;32:1655-1660.
20. Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR. The anti-malarial artesunate is also active against cancer. Int J Oncol 2001;18:767-773.
21. Efferth T, Sauerbrey A, Olbrich A, et al. Molecular modes of action of artesunate in tumor cell lines. Mol Pharmacol 2003;64:382-394.
22. Posner GH, McRiner AJ, Paik I-H, et al. Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents. J Med Chem 2004;47:1299-1301.
23. Jung M, Li X, Bustos DA, ElSohly HN, McChesney JD, Milhous WK. Synthesis and antimalarial activity of (+)-deoxoartemisinin. J Med Chem 1990;33:1516-1518.